Therapeutic and legal aspects of psilocybin in cancer-related depression
Depression prevalence is markedly elevated in oncological patients, particularly among head and neck cancer (HNC) cohorts, who face twice the prevalence of major depressive disorder (MDD) compared to other cancer populations. MDD in this context independently predicts poorer clinical outcomes and in...
Saved in:
| Main Authors: | Wierzbicka Małgorzata, Renata Kopczyk, Aleksandra Gerlach, Joanna Rymaszewska |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Psychiatry |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1591864/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the role of the psychedelic alkaloid psilocybin in alleviating cancer-related distress
by: Fejzić Dino
Published: (2025-03-01) -
Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative Care
by: Michel Dorval, et al.
Published: (2025-01-01) -
The psychedelic renaissance: psilocybin, a breakthrough for treatment resistant depression?
by: Trevor R. Norman
Published: (2025-08-01) -
Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity
by: Kinderlehrer DA
Published: (2025-01-01) -
Pharmacokinetics of Psilocybin: A Systematic Review
by: Shakila Meshkat, et al.
Published: (2025-03-01)